Granger, IN, United States of America

Arthur L Chlebowski

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arthur L Chlebowski: Innovator in Injection Device Technology

Introduction

Arthur L Chlebowski is a notable inventor based in Granger, IN (US). He has made significant contributions to the field of medical devices, particularly in the area of injection technology. His innovative approach has led to the development of a unique device that enhances the safety and efficiency of administering injections.

Latest Patents

Chlebowski holds a patent for a "Compact device for rapidly mixing and delivering substances to a patient." This device is designed for the injection of substances and features separate compartments for holding two distinct substances, which can be solid, liquid, or gas. The device allows for the mixing of these substances with minimal actions required from the operator, thereby reducing the risk of operator error. The design ensures that the needle remains sterile until the device is activated, enhancing safety for both the patient and the healthcare provider.

Career Highlights

Chlebowski is associated with Glucago LLC, where he continues to work on innovative solutions in the medical device sector. His focus on creating user-friendly and safe injection devices reflects his commitment to improving patient care. With a patent portfolio that includes 1 patent, he has established himself as a key player in the field of medical technology.

Collaborations

Chlebowski has collaborated with notable colleagues such as Rush L Bartlett, II and Peter M Greco, Jr. These partnerships have likely contributed to the development and refinement of his innovative devices.

Conclusion

Arthur L Chlebowski's contributions to injection device technology demonstrate his dedication to enhancing medical practices. His innovative designs not only improve the efficiency of administering injections but also prioritize patient safety.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…